Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Tyrosine-protein kinase ABL1 | ||
| Ligand | BDBM34751 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | TRFRET-based biochemical high throughput dose response assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1 | ||
| IC50 | 724.16±n/a nM | ||
| Citation |  PubChem, PC TRFRET-based biochemical high throughput dose response assay for inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) PubChem Bioassay(2012)[AID] | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Tyrosine-protein kinase ABL1 | |||
| Name: | Tyrosine-protein kinase ABL1 | ||
| Synonyms: | ABL | ABL1 | ABL1_HUMAN | Abelson murine leukemia viral oncogene homolog 1 | JTK7 | Proto-oncogene c-Abl | Proto-oncogene tyrosine-protein kinase ABL1 | Tyrosine-protein kinase (ABL) | Tyrosine-protein kinase ABL | Tyrosine-protein kinase ABL1 (ABL) | V-abl Abelson murine leukemia viral oncogene homolog 1 | c-ABL | p150 | tyrosine-protein kinase ABL1 isoform a | ||
| Type: | Enzyme | ||
| Mol. Mass.: | 122897.30 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P00519 | ||
| Residue: | 1130 | ||
| Sequence: |
| ||
| BDBM34751 | |||
| n/a | |||
| Name | BDBM34751 | ||
| Synonyms: | 2,6,7-trihydroxy-9-(2,4,5-trimethoxyphenyl)-3-xanthenone | 2,6,7-trihydroxy-9-(2,4,5-trimethoxyphenyl)-3H-xanthen-3-one | 2,6,7-trihydroxy-9-(2,4,5-trimethoxyphenyl)xanthen-3-one | 2,6,7-tris(oxidanyl)-9-(2,4,5-trimethoxyphenyl)xanthen-3-one | 9-asaryl-2,6,7-trihydroxy-fluorone | MLS000578559 | SMR000197746 | cid_2931982 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C22H18O8 | ||
| Mol. Mass. | 410.3735 | ||
| SMILES | COc1cc(OC)c(cc1OC)-c1c2cc(O)c(O)cc2oc2cc(=O)c(O)cc12 |(10.68,5.5,;9.35,4.73,;9.35,3.19,;10.68,2.42,;10.68,.88,;12.01,.11,;13.35,.88,;9.35,.11,;8.01,.88,;8.01,2.42,;6.68,3.19,;6.68,4.73,;9.35,-1.43,;10.68,-2.2,;12.06,-1.38,;13.45,-2.17,;14.78,-1.39,;13.45,-3.77,;14.78,-4.55,;12.06,-4.56,;10.68,-3.74,;9.35,-4.51,;8.01,-3.74,;6.63,-4.56,;5.24,-3.77,;3.91,-4.55,;5.24,-2.17,;3.91,-1.39,;6.63,-1.38,;8.01,-2.2,)| | ||
| Structure | 
| ||